Pavmed Inc Stock Filter Stocks by Fundamentals
| PAVM Stock | USD 1.18 0.07 6.31% |
PAVmed Inc fundamentals help investors to digest information that contributes to PAVmed's financial success or failures. It also enables traders to predict the movement of PAVmed Stock. The fundamental analysis module provides a way to measure PAVmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAVmed stock.
PAVmed | Shares Owned by Insiders |
PAVmed Current Valuation Drivers
We derive many important indicators used in calculating different scores of PAVmed from analyzing PAVmed's financial statements. These drivers represent accounts that assess PAVmed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PAVmed's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 30.8M | 21.4M | 100.6M | 42.8M | 29.8M | 57.7M | |
| Enterprise Value | 31.3M | 21.1M | 98.3M | 39.6M | 58.9M | 62.0M |
PAVmed Institutional Holders
Institutional Holdings refers to the ownership stake in PAVmed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of PAVmed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PAVmed's value.| Shares | Tower Research Capital Llc | 2024-09-30 | 3.7 K | Wells Fargo & Co | 2024-09-30 | 2.8 K | Atlantic Trust Group, Llc | 2024-06-30 | 836 | Hanson Mcclain Inc | 2024-09-30 | 447 | Advisor Group Holdings, Inc. | 2024-06-30 | 116 | Bank Of America Corp | 2024-06-30 | 79.0 | Parallel Advisors, Llc | 2024-09-30 | 78.0 | M&r Capital Management Inc | 2024-09-30 | 67.0 | Jpmorgan Chase & Co | 2024-09-30 | 20.0 | First Manhattan Co. Llc | 2024-09-30 | 600 K | Vanguard Group Inc | 2024-09-30 | 281 K |
PAVmed Fundamentals
| Return On Equity | -13.58 | ||||
| Return On Asset | -0.8 | ||||
| Operating Margin | (13.98) % | ||||
| Current Valuation | 49.32 M | ||||
| Shares Outstanding | 10.74 M | ||||
| Shares Owned By Insiders | 10.38 % | ||||
| Shares Owned By Institutions | 14.59 % | ||||
| Number Of Shares Shorted | 269.9 K | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 7.42 X | ||||
| Price To Sales | 3.11 X | ||||
| Revenue | 2.45 M | ||||
| Gross Profit | (3.24 M) | ||||
| EBITDA | (75.74 M) | ||||
| Net Income | (64.17 M) | ||||
| Cash And Equivalents | 68.47 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 48.73 M | ||||
| Debt To Equity | 0.79 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | (6.62) X | ||||
| Cash Flow From Operations | (52.04 M) | ||||
| Short Ratio | 9.07 X | ||||
| Earnings Per Share | (1.14) X | ||||
| Target Price | 9.67 | ||||
| Number Of Employees | 107 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 11.92 M | ||||
| Total Asset | 33.12 M | ||||
| Retained Earnings | (294.43 M) | ||||
| Working Capital | (29.68 M) | ||||
| Current Asset | 1.97 M | ||||
| Current Liabilities | 842 K | ||||
| Net Asset | 33.12 M |
About PAVmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out PAVmed Piotroski F Score and PAVmed Altman Z Score analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.